Diagnostic Medical Systems S.A. (EPA:ALDMS)

France flag France · Delayed Price · Currency is EUR
1.200
+0.005 (0.42%)
Jul 13, 2026, 5:35 PM CET
Market Cap31.10M +10.9%
Revenue (ttm)52.86M +8.2%
Net Income-167.00K
EPS-0.01
Shares Out 25.92M
PE Ration/a
Forward PE40.00
Dividendn/a
Ex-Dividend Daten/a
Volume3,047
Open1.200
Previous Close1.195
Day's Range1.190 - 1.200
52-Week Range1.160 - 1.485
Beta0.70
Analystsn/a
Price Targetn/a
Earnings DateSep 15, 2026

About EPA:ALDMS

Diagnostic Medical Systems S.A. designs, develops, manufactures, and sells medical imaging systems in France. The company offers ADAM, a software suite for imaging experts; R and F solutions, including Platinum Neo, Platinum Flex, and Optima; bone densitometers, including Stratos and Medix Series; MISTRAL, a manual chest and bone solution; and Camargue series which offers motorized radiographic systems to perform all types of bone and chest exams, including full spine and long leg exams. It also provides mobiles under the !M1, ONYX, Rafale/Rafa... [Read more]

Sector Healthcare
Founded 1979
Employees 146
Stock Exchange Euronext Paris
Ticker Symbol ALDMS
Full Company Profile

Financial Performance

In 2025, EPA:ALDMS's revenue was 52.86 million, an increase of 8.19% compared to the previous year's 48.86 million. Losses were -167,000, -94.20% less than in 2024.

Financial Statements